CALGARY, Alberta, Oct. 15, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- FluroTech Ltd., a technology company focused on the analytical cannabis and hemp testing market, has been awarded a Research License from Health Canada. The license permits the company to grow up to 144 cannabis plants from seed or clone and store up to 1 kg at its laboratory and cannabis research facility for use in the development of testing protocols for cannabinoids, heavy metals and other contaminants. Furthermore, the research license will allow for future development projects around pesticide and mold testing applications.
“The research license allows the company to accelerate the development of new applications of our base platform technology, the CompleTest, by not having to rely on third parties as extensively,” states Dr. Trevor MacMillan, Ph.D. and Director of Scientific Research at FluroTech. “Current projects in the development pipeline will be more efficient as the Company has the ability to grow plants in-house with biomarkers or heavy metals to optimize extraction protocols or study the uptake and distribution throughout the plant, receive samples from producers to expand our reference database, and establish decarboxylation procedures to test for cannabinoids throughout the entire supply chain. This will provide valuable data to producers working on products for the next wave of legalization.”
The company expects to release a low THCA testing protocol for hemp in the next month and release a cadmium testing protocol, the first of four heavy metal protocols, soon thereafter. Each new protocol represents a new revenue stream for the company and increased product differentiation from competitors utilizing HPLC technology.
